Pharmacological treatment assessment showed a statistically significant growing trend in all variables along the study visits (number of anti-HTN, ACE inhibitors/ARBs, aspirin, statins, oral hypoglycemic agents, insulin, and treatment compliance) (Table 3). This evidence concerns the gene INS and hypertensive disorder.